hashimoto's thyroiditis and glp 1 Can a patient with safely be treated with a GLP‑1 receptor agonist (e.g., liraglutide, semaglutide, dulaglutide)? Hashimoto's Thyroiditis | American Thyroid
Description
10.2337/dc21-2009 72 TahraniA
The choice should be individualized based on the primary indication (type 2 diabetes versus obesity), efficacy, side effect profile, dosing convenience, cost, and insurance coverage
State-level variations Anthem operates under different names and regulatory environments in different states
One area of research is dual agonists that target both GLP-1 and glucagon receptors that have the potential to provide enhanced metabolic benefits and more significant weight reduction
In response, compounding pharmacies began creating alternative formulations for patients who couldnt access or afford the name-brand versions
Double the intended dose
